Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Macrogenics (MGNX)

Macrogenics (MGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 388,645
  • Shares Outstanding, K 48,917
  • Annual Sales, $ 60,120 K
  • Annual Income, $ -171,450 K
  • 60-Month Beta 2.28
  • Price/Sales 6.71
  • Price/Cash Flow N/A
  • Price/Book 1.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.93
  • Number of Estimates 5
  • High Estimate -0.12
  • Low Estimate -1.44
  • Prior Year -1.06
  • Growth Rate Est. (year over year) +12.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.88 +4.57%
on 11/11/19
11.68 -29.45%
on 10/22/19
-3.14 (-27.59%)
since 10/11/19
3-Month
7.88 +4.57%
on 11/11/19
15.48 -46.77%
on 08/15/19
-5.73 (-41.02%)
since 08/12/19
52-Week
7.88 +4.57%
on 11/11/19
32.32 -74.50%
on 02/06/19
-8.38 (-50.42%)
since 11/12/18

Most Recent Stories

More News
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, OSTK, RUHN and REZI

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

MGNX : 8.25 (+3.90%)
OSTK : 7.78 (-17.41%)
RUHN : 7.02 (-0.43%)
REZI : 8.77 (-2.77%)
TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MacroGenics, Inc. ("MacroGenics" or "the Company") (NASDAQ: MGNX)...

MGNX : 8.25 (+3.90%)
DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against MacroGenics, Inc. ("MacroGenics" or "the Company") (NASDAQ: MGNX) and certain...

MGNX : 8.25 (+3.90%)
CLASS ACTION UPDATE for SNDL, DBX, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

SNDL : 3.81 (-1.80%)
DBX : 18.91 (+0.27%)
MGNX : 8.25 (+3.90%)
WTRH : 0.25 (unch)
MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 12, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in MacroGenics, Inc. (NASDAQ: MGNX) ("MacroGenics" or the "Company")...

MGNX : 8.25 (+3.90%)
MacroGenics Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 11, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in MacroGenics, Inc. (NASDAQ: MGNX) ("MacroGenics" or the "Company")...

MGNX : 8.25 (+3.90%)
Downtrend Call Working As Macrogenics Inc Stock Falls 58.2% (MGNX)

SmarTrend identified a Downtrend for Macrogenics Inc (NASDAQ:MGNX) on March 6th, 2019 at $19.60. In approximately 8 months, Macrogenics Inc has returned 58.16% as of today's recent price of $8.20.

MGNX : 8.25 (+3.90%)
Macrogenics Inc Falls 27.05% on Heavy Volume: Watch For Potential Rebound

Macrogenics Inc (NASDAQ:MGNX) traded in a range yesterday that spanned from a low of $8.14 to a high of $8.40. Yesterday, the shares fell 27.0%, which took the trading range below the 3-day low of $8.31...

MGNX : 8.25 (+3.90%)
SHAREHOLDER ALERT: PUMP MGNX VRAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

PUMP : 7.69 (+4.48%)
MGNX : 8.25 (+3.90%)
VRAY : 2.48 (-4.98%)
2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm

Hagens Berman urges MacroGenics (NASDAQ: MGNX) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they qualify to recover their investment losses. Only two days...

MGNX : 8.25 (+3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade MGNX with:

Business Summary

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics...

See More

Key Turning Points

2nd Resistance Point 8.59
1st Resistance Point 8.27
Last Price 8.25
1st Support Level 7.75
2nd Support Level 7.56

See More

52-Week High 32.32
Fibonacci 61.8% 22.98
Fibonacci 50% 20.10
Fibonacci 38.2% 17.22
Last Price 8.25
52-Week Low 7.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar